GEN Exclusives

More »

GEN News Highlights

More »
Feb 27, 2008

Scientists Demonstrate Effects of IL-8 Gene Silencing by Liposome-Encapsulated siRNA in Ovarian Cancer

  • Researchers found that Interleukin-8 (IL-8) production, which they associated with a lower median survival in ovarian cancer patients, can be stifled by a particular siRNA wrapped in a fatty nanoparticle.

    To examine IL-8's role in ovarian cancer, the researchers analyzed tumors from 102 patients diagnosed and treated between 1988 and 2006. Of those, 43 had tumors with high levels of IL-8 and 59 had low levels. The median survival of those with high IL-8 tumors was 1.62 years compared with 3.79 years for those with low expression.

    All 43 tumors with high expression of IL-8 were high grade, and 42 of 43 were advanced, either stage III or IV tumors. By comparison, 10 of 59 tumors with low IL-8 expression were early stage, and six were of low grade.

    The team also confirmed in a lab experiment that a specific siRNA silences IL-8. They then tested it against two lines of ovarian cancer in a mouse model. They packaged siRNA that stymies IL-8 into a small ball of liposome, a combination they developed to deliver siRNA to tumors.

    Injections of the IL-8 siRNA liposome shrank tumors in mice receiving the injection. Mice receiving the IL-8 siRNA plus taxane-based chemotherapy docetaxel had greater tumor reduction compared to just docetaxel.

    They also tested the approach in mice with an ovarian cancer cell line known to be resistant to taxane-based drugs. IL-8 siRNA alone reduced the size of these tumors by 47%, according to the research team. In combination with docetaxel it reduced tumor size by 77%, they add. The researchers hypothesize that the combination resensitizes a resistant tumor to taxanes.

    The study was conducted by investigators at the University of Texas M. D. Anderson Cancer Center, Nebraska Medical Center, and the University of Iowa. The paper is published in the Journal of the National Cancer Institute.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?